Hiroko Nobuta, PhD

Assistant Professor
Department of Neuroscience and Cell Biology
Resident Faculty at Center for Advanced Biotechnology and Medicine
PhD in Neuroscience, University of California Los Angeles, 2012
Postdoc, University of California San Francisco and Stanford University, 2012-2018, Albert Einstein College of Medicine, 2018-2020

Phone: (848) 445-9851
Email: nobuta@cabm.rutgers.edu
Office location: Center for Advanced Biotechnology and Medicine (CABM), Room 237, Piscataway, NJ 08854

Research Interests: The major goal of our research is to develop regenerative therapies for human oligodendrocyte disorders such as leukodystrophies, multiple sclerosis, and white matter injury associated with premature birth. The lab takes two approaches to achieve the goal: 1) gaining fundamental knowledge in human brain development, and 2) engineering transplantable human oligodendrocytes.

Current fundingCareer Transition Award, National Multiple Sclerosis Society

Nobuta H, Yang N, Ng YH, Marro SG, Sabeur K, Chavali M, Stockley JH, page1image181885840DW, Walter PB, Zhao C, Huie P, Goldman SA, Kriegstein AR, Franklin RJM, Rowitch D, Wernig M. Cell Stem Cell. 2019 Oct 3;25(4):531-541. Human Oligodendrocyte Death in Pelizaeus-Merzbacher Disease is Rescued by Iron Chelation.

“Next Generation Human Disease Models in Neuroscience.” A faculty presenter at virtual conference for the Society for Neuroscience. Viewable at https://neuronline.sfn.org/Articles/Scientific-Research/2019/Next-Generation-Human-Disease- Models-in-Neuroscience. Sep 2019

Generation of Oligodendrocytes from iPS Cells: Stem Cells and Reprogramming Methods for Neuroscience.” A faculty presenter at the Online Training Series for the Society for Neuroscience. Viewable at https://neuronline.sfn.org/. Aug 2019